Cytokinetics Inc (CYTK)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	1,401,670	1,436,060	1,523,790	808,082	824,316	740,614	779,899	889,815	1,014,780	1,075,960	771,717	856,253	841,319	827,539	564,302	577,062	533,803	474,112	232,495	256,582
Total stockholders’ equity	US$ in thousands	-135,372	-13,911	108,550	-396,160	-386,323	-438,801	-333,115	-229,020	-107,900	-15,977	111,414	116,261	243,863	249,020	16,489	67,846	113,383	149,605	-78,080	-45,711
Financial leverage ratio		—	—	14.04	—	—	—	—	—	—	—	6.93	7.36	3.45	3.32	34.22	8.51	4.71	3.17	—	—

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,401,670K ÷ $-135,372K
= —

The financial leverage ratio of Cytokinetics Inc has shown significant fluctuations over the reported periods.

- The ratio was not available (indicated as "—") for the periods ending March 31, 2020, and June 30, 2020.
- Starting from September 30, 2020, the ratio increased steadily, reaching 4.71 by December 31, 2020.
- The ratio spiked to 8.51 by March 31, 2021, indicating a substantial increase in financial leverage.
- A sharp decline was then observed by June 30, 2021, where the ratio dropped to 34.22, which may signify changes in the company's debt and equity structure.
- There was a subsequent decrease to 3.32 by September 30, 2021, followed by a slight increase to 3.45 by December 31, 2021.
- The ratio rose again to 7.36 by March 31, 2022, before declining to 6.93 by June 30, 2022.
- As of the latest data available, the financial leverage ratio stood at 14.04 on June 30, 2024.

These fluctuations suggest that Cytokinetics Inc has experienced varying levels of debt relative to its equity over the reporting periods, indicating potential shifts in the company's capital structure and financial risk profile. It would be important to analyze the factors driving these changes and assess their implications for the company's overall financial health and stability.